Clin2
NCT06892015Likely a fitRecruiting

Oropouche virus shedding and immune response study

Oropouche Infection

Part of Infections clinical trials.

This study monitors how long the Oropouche virus stays in the body and how the immune system responds after a positive diagnosis. It may help us better understand the course of the infection and improve patient care.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
30 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You have tested positive for Oropouche virus using a PCR test
  • You are 18 years old or older
  • You agree to take part in the study and allow the use of your data and leftover samples

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07592429Not yet recruiting
Immune memory after mpox infection

This study looks at how well your immune system remembers the mpox virus after you've been infected. It may help researchers understand protection against future infections.

NCT06432855Not yet recruiting
Study of genes and immune response in Oceanian populations

This study looks at how genes affect the immune system's response to viruses in people from Melanesian and European communities in New Caledonia. It may help understand why some people get sicker from viruses like dengue.

Noumea
NCT05879965Recruiting
Tracking immune responses after mpox, smallpox vaccine, or PrEP

This study follows people after confirmed mpox, after smallpox vaccination, or in people taking HIV PrEP to learn how the immune system responds over time. It may help scientists better understand protection and immune changes after these exposures.

Antwerp
NCT05654883Enrolling by invitation
Study of mpox immunity in people who were vaccinated or infected

This observational study looks at how your body’s defenses work against mpox (monkeypox), based on blood and health information. You may be eligible if you recently got an mpox vaccine or have had mpox infection and are now out of isolation.

New York, New York
NCT07055867Enrolling by invitation
Mpox outbreak study in Equateur, DR Congo

This study is looking at people with mpox in the DR Congo to learn more about the outbreak. If you have a rash that fits the mpox pattern and a positive lab test, you may be able to join.

Mbandaka, Équateur Province
NCT07534267Not yet recruiting
Tracking mpox spread and vaccine effectiveness in West Africa

This study follows people with mpox and their close contacts in Guinea to learn how the virus spreads and to measure how well the mpox vaccine works. You would be involved for up to two months and help improve prevention and care.

Conakry

Hear when a new Oropouche Infection trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.